Altimmune Balance Sheet Health
Financial Health criteria checks 6/6
Altimmune has a total shareholder equity of $133.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $147.9M and $14.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$139.38m |
| Equity | US$133.38m |
| Total liabilities | US$14.49m |
| Total assets | US$147.86m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A4C's short term assets ($145.8M) exceed its short term liabilities ($8.6M).
Long Term Liabilities: 0A4C's short term assets ($145.8M) exceed its long term liabilities ($5.8M).
Debt to Equity History and Analysis
Debt Level: 0A4C is debt free.
Reducing Debt: 0A4C has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A4C has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0A4C has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 28.3% each year.